Samuel Levin, 91, is helped by RNs Latoya Harris and Shelley Chinnery-Antoine as he finishes receiving monoclonal antibody therapy, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. Levin, who is vaccinated, experienced very mild symptoms, but his doctor urged him to get the antibody therapy because of his age. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, because of the scarcity of the one monoclonal antibody therapy proven to be effective against the omicron variant of Covid-19, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RN Latoya Harris helps Samuel Levin, 91, finish receiving monoclonal antibody therapy, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. Levin, who is vaccinated, experienced very mild symptoms, but his doctor urged him to get the antibody therapy because of his age. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, because of the scarcity of the one monoclonal antibody therapy proven to be effective against the omicron variant of Covid-19, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RN Arabion Gillyard wears compression socks to help her legs as she is on her feet all day working in the monoclonal antibody therapy clinic, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RNs Latoya Harris, Arabion Gillyard, Shelley Chinnery-Antoine and Sonja Shipman work in the infusion room providing monoclonal antibody therapy, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RN Sonja Shipman checks on the status of the monoclonal antibody therapy of Sherman H. Hink, 92, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. Hink said he was mostly asymptomatic and discovered he was positive for Covid-19 after taking a test after learning he had had lunch with relatives who ended up positive for the virus. Because of his age, Hink’s doctor urged him to receive the monoclonal antibody therapy. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RNs Latoya Harris and Arabion Gillyard finish administering monoclonal antibody therapy to Sherman H. Hink, 92, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. Hink said he was mostly asymptomatic and discovered he was positive for Covid-19 after taking a test after learning he had had lunch with relatives who ended up positive for the virus. Because of his age, Hink’s doctor urged him to receive the monoclonal antibody therapy. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RN Latoya Harris, left, helps finish the administration of monoclonal antibody therapy for Sherman H. Hink, 92, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. Hink said he was mostly asymptomatic and discovered he was positive for Covid-19 after taking a test after learning he had had lunch with relatives who ended up positive for the virus. Because of his age, Hink’s doctor urged him to receive the monoclonal antibody therapy. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RN Arabion Gillyard removes the IV used to administer monoclonal antibody therapy to Sherman H. Hink, 92, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. Hink said he was mostly asymptomatic and discovered he was positive for Covid-19 after taking a test after learning he had had lunch with relatives who ended up positive for the virus. Because of his age, Hink’s doctor urged him to receive the monoclonal antibody therapy. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RNs Latoya Harris and Arabion Gillyard finish administering monoclonal antibody therapy to Sherman H. Hink, 92, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. Hink said he was mostly asymptomatic and discovered he was positive for Covid-19 after taking a test after learning he had had lunch with relatives who ended up positive for the virus. Because of his age, Hink’s doctor urged him to receive the monoclonal antibody therapy. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
RNs Sonja Shipman and Latoya Harris work in the monoclonal antibody therapy clinic, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
A portrait of Bess Smith, whose husband the Rev. Angie Frank Smith was an early trustee of the hospital, hangs on the wall inside the monoclonal antibody therapy clinic, Friday, Jan. 21, 2022, at Houston Methodist Texas Medical Center in Houston. The hospital repurposed a first-floor multipurpose room and set it up as its infusion center earlier in the pandemic. At the height of the pandemic, nurses in the room would infuse up to 150 patients a day with the monoclonal antibody therapy, and just one month ago they were serving 70 to 80 patients a day. Now, with scarcity of the one monoclonal antibody therapy proven to be effective against omicron, the hospital can only provide the therapy for 15 patients a day.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
People wait in line at a Curative Covid-19 testing site at the University of Houston-Downtown, Monday, Dec. 20, 2021, in Houston.
Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less
Research technician Kyle Palmer works to add reagents to the RNA that has been extracted from the waste water, the reagent helps qualify the variant and amount of COVID-19, inside the Stadler lab at Rice University’s Brown School of Engineering on Friday, April 9, 2021, in Houston. Rice University, Baylor College of Medicine and Houston Health Department have created a 200-location system to find sars-COV-2 in the city’s wastewater. By analyzing sewage, the scientists and city are able to see which neighborhoods are still affected by the virus, where the UK variant is most prevalent and if Houston is developing its own variant.
Godofredo A. Vásquez, Houston Chronicle / Staff photographerShow MoreShow LessHouston is poised to officially hit 400,000 COVID cases Monday, about a month after the city crossed the 300,000-case mark, as infections level off across the region.
The Houston Health Department on Friday reported 3,286 new and backlogged cases to bring the total number to 399,987, including recoveries and deaths. That means the virus has infected about 17 percent of Houstonians since the start of the pandemic.
Website
e-Edition
App
